img

Global Complement Drug for Blood Disease Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Complement Drug for Blood Disease Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Complement Drug for Blood Disease Market
The global Complement Drug for Blood Disease market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Complement Drug for Blood Disease is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Complement Drug for Blood Disease is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Complement Drug for Blood Disease is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Complement Drug for Blood Disease include Amyndas, Apellis, Novartis, Roche, Regeneron, Amgen, Samsung Bioepis, Alnylam and Akari Therapeutics, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Complement Drug for Blood Disease market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Complement Drug for Blood Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Complement Drug for Blood Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Complement Drug for Blood Disease revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Complement Drug for Blood Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Complement Drug for Blood Disease revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amyndas, Apellis, Novartis, Roche, Regeneron, Amgen, Samsung Bioepis, Alnylam and Akari Therapeutics, etc.



By Company


Amyndas
Apellis
Novartis
Roche
Regeneron
Amgen
Samsung Bioepis
Alnylam
Akari Therapeutics
UCB
Segment by Type
Peptides
Antibodies
Others

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Complement Drug for Blood Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Complement Drug for Blood Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Complement Drug for Blood Disease revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement Drug for Blood Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Peptides
1.2.3 Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Complement Drug for Blood Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complement Drug for Blood Disease Market Perspective (2018-2034)
2.2 Global Complement Drug for Blood Disease Growth Trends by Region
2.2.1 Complement Drug for Blood Disease Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Complement Drug for Blood Disease Historic Market Size by Region (2018-2024)
2.2.3 Complement Drug for Blood Disease Forecasted Market Size by Region (2024-2034)
2.3 Complement Drug for Blood Disease Market Dynamics
2.3.1 Complement Drug for Blood Disease Industry Trends
2.3.2 Complement Drug for Blood Disease Market Drivers
2.3.3 Complement Drug for Blood Disease Market Challenges
2.3.4 Complement Drug for Blood Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Complement Drug for Blood Disease by Players
3.1.1 Global Complement Drug for Blood Disease Revenue by Players (2018-2024)
3.1.2 Global Complement Drug for Blood Disease Revenue Market Share by Players (2018-2024)
3.2 Global Complement Drug for Blood Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Complement Drug for Blood Disease, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Complement Drug for Blood Disease Market Concentration Ratio
3.4.1 Global Complement Drug for Blood Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement Drug for Blood Disease Revenue in 2022
3.5 Global Key Players of Complement Drug for Blood Disease Head office and Area Served
3.6 Global Key Players of Complement Drug for Blood Disease, Product and Application
3.7 Global Key Players of Complement Drug for Blood Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Drug for Blood Disease Breakdown Data by Type
4.1 Global Complement Drug for Blood Disease Historic Market Size by Type (2018-2024)
4.2 Global Complement Drug for Blood Disease Forecasted Market Size by Type (2024-2034)
5 Complement Drug for Blood Disease Breakdown Data by Application
5.1 Global Complement Drug for Blood Disease Historic Market Size by Application (2018-2024)
5.2 Global Complement Drug for Blood Disease Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Complement Drug for Blood Disease Market Size (2018-2034)
6.2 North America Complement Drug for Blood Disease Market Size by Type
6.2.1 North America Complement Drug for Blood Disease Market Size by Type (2018-2024)
6.2.2 North America Complement Drug for Blood Disease Market Size by Type (2024-2034)
6.2.3 North America Complement Drug for Blood Disease Market Share by Type (2018-2034)
6.3 North America Complement Drug for Blood Disease Market Size by Application
6.3.1 North America Complement Drug for Blood Disease Market Size by Application (2018-2024)
6.3.2 North America Complement Drug for Blood Disease Market Size by Application (2024-2034)
6.3.3 North America Complement Drug for Blood Disease Market Share by Application (2018-2034)
6.4 North America Complement Drug for Blood Disease Market Size by Country
6.4.1 North America Complement Drug for Blood Disease Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Complement Drug for Blood Disease Market Size by Country (2018-2024)
6.4.3 North America Complement Drug for Blood Disease Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Complement Drug for Blood Disease Market Size (2018-2034)
7.2 Europe Complement Drug for Blood Disease Market Size by Type
7.2.1 Europe Complement Drug for Blood Disease Market Size by Type (2018-2024)
7.2.2 Europe Complement Drug for Blood Disease Market Size by Type (2024-2034)
7.2.3 Europe Complement Drug for Blood Disease Market Share by Type (2018-2034)
7.3 Europe Complement Drug for Blood Disease Market Size by Application
7.3.1 Europe Complement Drug for Blood Disease Market Size by Application (2018-2024)
7.3.2 Europe Complement Drug for Blood Disease Market Size by Application (2024-2034)
7.3.3 Europe Complement Drug for Blood Disease Market Share by Application (2018-2034)
7.4 Europe Complement Drug for Blood Disease Market Size by Country
7.4.1 Europe Complement Drug for Blood Disease Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Complement Drug for Blood Disease Market Size by Country (2018-2024)
7.4.3 Europe Complement Drug for Blood Disease Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Complement Drug for Blood Disease Market Size (2018-2034)
8.2 China Complement Drug for Blood Disease Market Size by Type
8.2.1 China Complement Drug for Blood Disease Market Size by Type (2018-2024)
8.2.2 China Complement Drug for Blood Disease Market Size by Type (2024-2034)
8.2.3 China Complement Drug for Blood Disease Market Share by Type (2018-2034)
8.3 China Complement Drug for Blood Disease Market Size by Application
8.3.1 China Complement Drug for Blood Disease Market Size by Application (2018-2024)
8.3.2 China Complement Drug for Blood Disease Market Size by Application (2024-2034)
8.3.3 China Complement Drug for Blood Disease Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Complement Drug for Blood Disease Market Size (2018-2034)
9.2 Asia Complement Drug for Blood Disease Market Size by Type
9.2.1 Asia Complement Drug for Blood Disease Market Size by Type (2018-2024)
9.2.2 Asia Complement Drug for Blood Disease Market Size by Type (2024-2034)
9.2.3 Asia Complement Drug for Blood Disease Market Share by Type (2018-2034)
9.3 Asia Complement Drug for Blood Disease Market Size by Application
9.3.1 Asia Complement Drug for Blood Disease Market Size by Application (2018-2024)
9.3.2 Asia Complement Drug for Blood Disease Market Size by Application (2024-2034)
9.3.3 Asia Complement Drug for Blood Disease Market Share by Application (2018-2034)
9.4 Asia Complement Drug for Blood Disease Market Size by Region
9.4.1 Asia Complement Drug for Blood Disease Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Complement Drug for Blood Disease Market Size by Region (2018-2024)
9.4.3 Asia Complement Drug for Blood Disease Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Type
10.2.1 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Application
10.3.1 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Country
10.4.1 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amyndas
11.1.1 Amyndas Company Details
11.1.2 Amyndas Business Overview
11.1.3 Amyndas Complement Drug for Blood Disease Introduction
11.1.4 Amyndas Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.1.5 Amyndas Recent Developments
11.2 Apellis
11.2.1 Apellis Company Details
11.2.2 Apellis Business Overview
11.2.3 Apellis Complement Drug for Blood Disease Introduction
11.2.4 Apellis Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.2.5 Apellis Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Complement Drug for Blood Disease Introduction
11.3.4 Novartis Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Complement Drug for Blood Disease Introduction
11.4.4 Roche Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.4.5 Roche Recent Developments
11.5 Regeneron
11.5.1 Regeneron Company Details
11.5.2 Regeneron Business Overview
11.5.3 Regeneron Complement Drug for Blood Disease Introduction
11.5.4 Regeneron Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.5.5 Regeneron Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Complement Drug for Blood Disease Introduction
11.6.4 Amgen Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.6.5 Amgen Recent Developments
11.7 Samsung Bioepis
11.7.1 Samsung Bioepis Company Details
11.7.2 Samsung Bioepis Business Overview
11.7.3 Samsung Bioepis Complement Drug for Blood Disease Introduction
11.7.4 Samsung Bioepis Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.7.5 Samsung Bioepis Recent Developments
11.8 Alnylam
11.8.1 Alnylam Company Details
11.8.2 Alnylam Business Overview
11.8.3 Alnylam Complement Drug for Blood Disease Introduction
11.8.4 Alnylam Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.8.5 Alnylam Recent Developments
11.9 Akari Therapeutics
11.9.1 Akari Therapeutics Company Details
11.9.2 Akari Therapeutics Business Overview
11.9.3 Akari Therapeutics Complement Drug for Blood Disease Introduction
11.9.4 Akari Therapeutics Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.9.5 Akari Therapeutics Recent Developments
11.10 UCB
11.10.1 UCB Company Details
11.10.2 UCB Business Overview
11.10.3 UCB Complement Drug for Blood Disease Introduction
11.10.4 UCB Revenue in Complement Drug for Blood Disease Business (2018-2024)
11.10.5 UCB Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Complement Drug for Blood Disease Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Peptides
Table 3. Key Players of Antibodies
Table 4. Key Players of Others
Table 5. Global Complement Drug for Blood Disease Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Complement Drug for Blood Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Complement Drug for Blood Disease Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Complement Drug for Blood Disease Market Share by Region (2018-2024)
Table 9. Global Complement Drug for Blood Disease Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Complement Drug for Blood Disease Market Share by Region (2024-2034)
Table 11. Complement Drug for Blood Disease Market Trends
Table 12. Complement Drug for Blood Disease Market Drivers
Table 13. Complement Drug for Blood Disease Market Challenges
Table 14. Complement Drug for Blood Disease Market Restraints
Table 15. Global Complement Drug for Blood Disease Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Complement Drug for Blood Disease Revenue Share by Players (2018-2024)
Table 17. Global Top Complement Drug for Blood Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug for Blood Disease as of 2022)
Table 18. Global Complement Drug for Blood Disease Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Complement Drug for Blood Disease Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Complement Drug for Blood Disease, Headquarters and Area Served
Table 21. Global Key Players of Complement Drug for Blood Disease, Product and Application
Table 22. Global Key Players of Complement Drug for Blood Disease, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Complement Drug for Blood Disease Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Complement Drug for Blood Disease Revenue Market Share by Type (2018-2024)
Table 26. Global Complement Drug for Blood Disease Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Complement Drug for Blood Disease Revenue Market Share by Type (2024-2034)
Table 28. Global Complement Drug for Blood Disease Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Complement Drug for Blood Disease Revenue Share by Application (2018-2024)
Table 30. Global Complement Drug for Blood Disease Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Complement Drug for Blood Disease Revenue Share by Application (2024-2034)
Table 32. North America Complement Drug for Blood Disease Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Complement Drug for Blood Disease Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Complement Drug for Blood Disease Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Complement Drug for Blood Disease Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Complement Drug for Blood Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Complement Drug for Blood Disease Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Complement Drug for Blood Disease Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Complement Drug for Blood Disease Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Complement Drug for Blood Disease Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Complement Drug for Blood Disease Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Complement Drug for Blood Disease Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Complement Drug for Blood Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Complement Drug for Blood Disease Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Complement Drug for Blood Disease Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Complement Drug for Blood Disease Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Complement Drug for Blood Disease Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Complement Drug for Blood Disease Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Complement Drug for Blood Disease Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Complement Drug for Blood Disease Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Complement Drug for Blood Disease Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Complement Drug for Blood Disease Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Complement Drug for Blood Disease Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Complement Drug for Blood Disease Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Complement Drug for Blood Disease Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Complement Drug for Blood Disease Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Complement Drug for Blood Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size by Country (2024-2034) & (US$ Million)
Table 64. Amyndas Company Details
Table 65. Amyndas Business Overview
Table 66. Amyndas Complement Drug for Blood Disease Product
Table 67. Amyndas Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 68. Amyndas Recent Developments
Table 69. Apellis Company Details
Table 70. Apellis Business Overview
Table 71. Apellis Complement Drug for Blood Disease Product
Table 72. Apellis Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 73. Apellis Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Complement Drug for Blood Disease Product
Table 77. Novartis Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Complement Drug for Blood Disease Product
Table 82. Roche Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 83. Roche Recent Developments
Table 84. Regeneron Company Details
Table 85. Regeneron Business Overview
Table 86. Regeneron Complement Drug for Blood Disease Product
Table 87. Regeneron Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 88. Regeneron Recent Developments
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Complement Drug for Blood Disease Product
Table 92. Amgen Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 93. Amgen Recent Developments
Table 94. Samsung Bioepis Company Details
Table 95. Samsung Bioepis Business Overview
Table 96. Samsung Bioepis Complement Drug for Blood Disease Product
Table 97. Samsung Bioepis Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 98. Samsung Bioepis Recent Developments
Table 99. Alnylam Company Details
Table 100. Alnylam Business Overview
Table 101. Alnylam Complement Drug for Blood Disease Product
Table 102. Alnylam Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 103. Alnylam Recent Developments
Table 104. Akari Therapeutics Company Details
Table 105. Akari Therapeutics Business Overview
Table 106. Akari Therapeutics Complement Drug for Blood Disease Product
Table 107. Akari Therapeutics Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 108. Akari Therapeutics Recent Developments
Table 109. UCB Company Details
Table 110. UCB Business Overview
Table 111. UCB Complement Drug for Blood Disease Product
Table 112. UCB Revenue in Complement Drug for Blood Disease Business (2018-2024) & (US$ Million)
Table 113. UCB Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Complement Drug for Blood Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Complement Drug for Blood Disease Market Share by Type: 2022 VS 2034
Figure 3. Peptides Features
Figure 4. Antibodies Features
Figure 5. Others Features
Figure 6. Global Complement Drug for Blood Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Complement Drug for Blood Disease Market Share by Application: 2022 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Complement Drug for Blood Disease Report Years Considered
Figure 12. Global Complement Drug for Blood Disease Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Complement Drug for Blood Disease Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Complement Drug for Blood Disease Market Share by Region: 2022 VS 2034
Figure 15. Global Complement Drug for Blood Disease Market Share by Players in 2022
Figure 16. Global Top Complement Drug for Blood Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug for Blood Disease as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Complement Drug for Blood Disease Revenue in 2022
Figure 18. North America Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Complement Drug for Blood Disease Market Share by Type (2018-2034)
Figure 20. North America Complement Drug for Blood Disease Market Share by Application (2018-2034)
Figure 21. North America Complement Drug for Blood Disease Market Share by Country (2018-2034)
Figure 22. United States Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Complement Drug for Blood Disease Market Size YoY (2018-2034) & (US$ Million)
Figure 25. Europe Complement Drug for Blood Disease Market Share by Type (2018-2034)
Figure 26. Europe Complement Drug for Blood Disease Market Share by Application (2018-2034)
Figure 27. Europe Complement Drug for Blood Disease Market Share by Country (2018-2034)
Figure 28. Germany Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. China Complement Drug for Blood Disease Market Size YoY (2018-2034) & (US$ Million)
Figure 35. China Complement Drug for Blood Disease Market Share by Type (2018-2034)
Figure 36. China Complement Drug for Blood Disease Market Share by Application (2018-2034)
Figure 37. Asia Complement Drug for Blood Disease Market Size YoY (2018-2034) & (US$ Million)
Figure 38. Asia Complement Drug for Blood Disease Market Share by Type (2018-2034)
Figure 39. Asia Complement Drug for Blood Disease Market Share by Application (2018-2034)
Figure 40. Asia Complement Drug for Blood Disease Market Share by Region (2018-2034)
Figure 41. Japan Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. South Korea Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. China Taiwan Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. India Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Australia Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Size YoY (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Share by Type (2018-2034)
Figure 49. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Share by Application (2018-2034)
Figure 50. Middle East, Africa, and Latin America Complement Drug for Blood Disease Market Share by Country (2018-2034)
Figure 51. Brazil Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Mexico Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Turkey Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Israel Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. GCC Countries Complement Drug for Blood Disease Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Amyndas Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 58. Apellis Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 59. Novartis Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 60. Roche Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 61. Regeneron Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 62. Amgen Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 63. Samsung Bioepis Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 64. Alnylam Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 65. Akari Therapeutics Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 66. UCB Revenue Growth Rate in Complement Drug for Blood Disease Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed